Prognostic Value of Neutrophil-Related Factors in Locally Advanced Cervical Squamous Cell Carcinoma Patients Treated with Cisplatin-Based Concurrent Chemoradiotherapy

Table 3

Multivariate survival analysis of OS in patients with LACSCC.

Clinicopathologic characteristics		SE	Wald	value	HR	95% CI
Lymph node metastasis	0.626	0.516	1.475	0.225	1.870	0.681–5.139
FIGO stage	0.188	0.495	0.144	0.704	1.207	0.457–3.185
NLR	−1.316	0.631	4.350	0.037	0.268	0.078–0.924

OS, overall survival; LACSCC, locally advanced cervical squamous cell carcinomas; FIGO, International Federation of Gynecology and Obstetrics; NLR, neutrophil-lymphocyte ratio.